Black Diamond Therapeutics
BDTX | NASDAQ
$1.53
+$0.06 (+4.08%)
At close: Nov 16, 2026, 4:00 PM ET
$1.49
-$0.04 (-2.92%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+4.08%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #729/1021 (Top 71%)
Key Statistics
Market Data
Market Cap $87.93M
1D Range
1.40 1.53
52W Range
1.40 4.01
Valuation (TTM)
PE -2.01
PB 1.00
EV/EBITDA -0.04
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $8.00
Cash Flow
FCF Yield -37.0%
SBC Adj. FCF Yield -44.5%
SBC Impact -20.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y 0.0% |
50.0%
Dil EPS 3Y | 5Y 53.3% |
47.6%
FCF 3Y | 5Y 36.4% |
46.9%
Returns
ROA -38.1%
ROE -44.0%
ROIC -51.0%
Financial Health
Net Cash
$102.03M
Current Ratio 6.92
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically charac...
Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Jan 31, 2020
Website www.blackdiamondtherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$8.00
Upside
+422.88%
Buy (4)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BDTX